{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:11:22Z","timestamp":1774858282024,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10736-6","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T16:42:26Z","timestamp":1741884146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The efficacy of COVID-19 vaccination in cystic fibrosis patients: a systematic review"],"prefix":"10.1186","volume":"25","author":[{"given":"Azam Gholami","family":"Shahrebabak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Shahpar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazanin Zeinali","family":"Nezhad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Sharifi","family":"Sarasyabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Nakhaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam Gholami","family":"Shahrebabak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razman Arabzadeh","family":"Bahri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"issue":"13","key":"10736_CR1","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239\u201342.","journal-title":"JAMA"},{"key":"10736_CR2","unstructured":"COVID - Coronavirus Statistics. - Worldometer [Internet]. [cited 2024 Jun 21]. Available from: https:\/\/www.worldometers.info\/coronavirus\/?"},{"issue":"18","key":"10736_CR3","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"YH W-j G, Z-y N","year":"2020","unstructured":"W-j G, Z-y N YH, W-h L. C-q O, J-x H. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708\u201320.","journal-title":"N Engl J Med"},{"issue":"2","key":"10736_CR4","doi-asserted-by":"publisher","first-page":"020503","DOI":"10.7189\/jogh.10.020503","volume":"10","author":"MMA Khan","year":"2020","unstructured":"Khan MMA, Khan MN, Mustagir MG, Rana J, Islam MS, Kabir MI. Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis. J Glob Health. 2020;10(2):020503.","journal-title":"J Glob Health"},{"issue":"6198","key":"10736_CR5","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.1255825","volume":"345","author":"MJ Hoegger","year":"2014","unstructured":"Hoegger MJ, Fischer AJ, McMenimen JD, Ostedgaard LS, Tucker AJ, Awadalla MA. Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis. Science. 2014;345(6198):818\u201322.","journal-title":"Science"},{"issue":"6","key":"10736_CR6","first-page":"584","volume":"78","author":"JA L\u00f3pez-Valdez","year":"2021","unstructured":"L\u00f3pez-Valdez JA, Aguilar-Alonso LA, G\u00e1ndara-Quezada V, Ruiz-Rico GE, \u00c1vila-Soledad JM, Reyes AA, et al. Cystic fibrosis: current concepts. Bol Med Hosp Infant Mex. 2021;78(6):584\u201396.","journal-title":"Bol Med Hosp Infant Mex"},{"issue":"5","key":"10736_CR7","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/S2213-2600(20)30177-6","volume":"8","author":"C Colombo","year":"2020","unstructured":"Colombo C, Burgel PR, Gartner S, van Koningsbruggen-Rietschel S, Naehrlich L, Sermet-Gaudelus I, et al. Impact of COVID-19 on people with cystic fibrosis. Lancet Respir Med. 2020;8(5):e35\u20136.","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10736_CR8","doi-asserted-by":"publisher","first-page":"e23937","DOI":"10.1002\/jcla.23937","volume":"35","author":"X Han","year":"2021","unstructured":"Han X, Xu P, Ye Q. Analysis of COVID-19 vaccines: types, thoughts, and application. J Clin Lab Anal. 2021;35(9):e23937.","journal-title":"J Clin Lab Anal"},{"issue":"5","key":"10736_CR9","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jinf.2021.12.044","volume":"84","author":"HJ Whitaker","year":"2022","unstructured":"Whitaker HJ, Tsang RSM, Byford R, Andrews NJ, Sherlock J, Sebastian Pillai P, et al. Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups. J Infect. 2022;84(5):675\u201383.","journal-title":"J Infect"},{"issue":"6","key":"10736_CR10","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jcf.2014.02.002","volume":"13","author":"MJ Browning","year":"2014","unstructured":"Browning MJ, Lim MTC, Kenia P, Whittle M, Doffinger R, Barcenas-Morales G, et al. Pneumococcal polysaccharide vaccine responses are impaired in a subgroup of children with cystic fibrosis. J Cyst Fibros. 2014;13(6):632\u20138.","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10736_CR11","first-page":"CD001753","volume":"2014","author":"P Dharmaraj","year":"2014","unstructured":"Dharmaraj P, Smyth RL. Vaccines for preventing influenza in people with cystic fibrosis. Cochrane Database Syst Rev. 2014;2014(3):CD001753.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10736_CR12","first-page":"1","volume":"3","author":"M Halim","year":"2021","unstructured":"Halim M, Halim A, Tjhin Y. COVID-19 vaccination efficacy and safety literature review. J Clin Med Res. 2021;3(1):1\u201310.","journal-title":"J Clin Med Res"},{"issue":"28","key":"10736_CR13","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1016\/j.vaccine.2023.05.041","volume":"41","author":"G Alicandro","year":"2023","unstructured":"Alicandro G, Orena BS, Rosazza C, Cariani L, Russo M, Zatelli M, et al. Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis. Vaccine. 2023;41(28):4114\u201320.","journal-title":"Vaccine"},{"issue":"3","key":"10736_CR14","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/j.jcf.2022.02.009","volume":"21","author":"G Alicandro","year":"2022","unstructured":"Alicandro G, Dacc\u00f3 V, Cariani L, Contarini M, Morlacchi LC, Rosazza C, et al. Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over. J Cyst Fibros. 2022;21(3):e173\u20135.","journal-title":"J Cyst Fibros"},{"issue":"8","key":"10736_CR15","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.3390\/biomedicines10081998","volume":"10","author":"G Alicandro","year":"2022","unstructured":"Alicandro G, Dacc\u00f2 V, Cariani L, Rosazza C, Sciarrabba CS, Ferraro F, et al. Immunogenicity of BNT162b2 mRNA-Based vaccine against SARS-CoV-2 in people with cystic fibrosis according to disease characteristics and maintenance therapies. Biomedicines. 2022;10(8):1998.","journal-title":"Biomedicines"},{"issue":"2","key":"10736_CR16","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/ijms24020908","volume":"24","author":"F Lucca","year":"2023","unstructured":"Lucca F, Bezzerri V, Danese E, Olioso D, Peserico D, Boni C, et al. Immunogenicity and safety of the BNT162b2 COVID-19 vaccine in patients with cystic fibrosis with or without lung transplantation. Int J Mol Sci. 2023;24(2):908.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10736_CR17","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1002\/ppul.26528","volume":"58","author":"GE Hergenroeder","year":"2023","unstructured":"Hergenroeder GE, Faino AV, Cogen JD, Genatossio A, McNamara S, Pascual M, et al. Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis. Pediatr Pulmonol. 2023;58(9):2478\u201386.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10736_CR18","doi-asserted-by":"publisher","first-page":"2200502","DOI":"10.1183\/13993003.00502-2022","volume":"61","author":"G Dauriat","year":"2023","unstructured":"Dauriat G, Beaumont L, Luong Nguyen LB, Renaud Picard B, Penhouet M, Coiffard B, et al. Efficacy of three COVID-19 vaccine doses in lung transplant recipients: a multicentre cohort study. Eur Respir J. 2023;61(1):2200502.","journal-title":"Eur Respir J"},{"issue":"3","key":"10736_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3390\/vaccines11030657","volume":"11","author":"T Fuchs","year":"2023","unstructured":"Fuchs T, Appelt D, Ellemunter H. Is there a difference in immune response to SARS-CoV-2 vaccination between liver and lung transplant patients with cystic fibrosis?? Vaccines. 2023;11(3):657.","journal-title":"Vaccines"},{"issue":"3","key":"10736_CR20","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1016\/j.jcf.2022.04.004","volume":"21","author":"A Michos","year":"2022","unstructured":"Michos A, Filippatos F, Tatsi EB, Dellis C, Efthymiou V, Zarkada I, et al. Immunogenicity of the COVID-19 BNT162b2 vaccine in adolescents and young adults with cystic fibrosis. J Cyst Fibros Off J Eur Cyst Fibros Soc. 2022;21(3):e184\u20137.","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"issue":"3","key":"10736_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jcf.2020.04.012","volume":"19","author":"R Cosgriff","year":"2020","unstructured":"Cosgriff R, Ahern S, Bell SC, Brownlee K, Burgel PR, Byrnes C, et al. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis. J Cyst Fibros Off J Eur Cyst Fibros Soc. 2020;19(3):355\u20138.","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"issue":"6","key":"10736_CR22","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jcf.2020.10.003","volume":"19","author":"E McClenaghan","year":"2020","unstructured":"McClenaghan E, Cosgriff R, Brownlee K, Ahern S, Burgel PR, Byrnes CA, et al. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis. J Cyst Fibros. 2020;19(6):868\u201371.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10736_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12890-021-01528-0","volume":"21","author":"HR Mathew","year":"2021","unstructured":"Mathew HR, Choi MY, Parkins MD, Fritzler MJ. Systematic review: cystic fibrosis in the SARS-CoV-2\/COVID-19 pandemic. BMC Pulm Med. 2021;21(1):173.","journal-title":"BMC Pulm Med"},{"issue":"11","key":"10736_CR24","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.3390\/jcm9113624","volume":"9","author":"H Corvol","year":"2020","unstructured":"Corvol H, de Miranda S, Lemonnier L, Kemgang A, Reynaud Gaubert M, Chiron R, et al. First wave of COVID-19 in French patients with cystic fibrosis. J Clin Med. 2020;9(11):3624.","journal-title":"J Clin Med"},{"issue":"1","key":"10736_CR25","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1097\/TP.0000000000003966","volume":"106","author":"TW Hoffman","year":"2022","unstructured":"Hoffman TW, Meek B, Rijkers GT, van Kessel DA. Poor serologic response to 2 doses of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients. Transplantation. 2022;106(1):e103\u20134.","journal-title":"Transplantation"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10736-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10736-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10736-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T16:42:28Z","timestamp":1741884148000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10736-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10736"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10736-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a systematic review of previously published literature and does not involve direct contact with human subjects or animals. We are utilizing data extracted from previously published articles. Therefore, there are no specific ethical challenges associated with our research methodology. Consequently, we did not include a reference to a specific norm or standard such as the Declaration of Helsinki. However, we assure that our research adheres to the highest standards of scientific integrity and ethical conduct in reviewing and analyzing published literature. The systematic review process was conducted in accordance with established guidelines for evidence synthesis and reporting.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest concerning the publication of this article. Each author listed assumes responsibility for the overall integrity of the work and has provided consent for the publication of this version.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"358"}}